[CLDX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -52.94%
YoY- -43.79%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 163 174 333 153 3,480 685 3,786 -87.78%
PBT -36,004 -23,050 -20,148 -20,679 -13,373 -16,538 -22,839 35.56%
Tax 16,564 -1,486 -874 -227 382 764 -939 -
NP -52,568 -21,564 -20,148 -20,452 -13,373 -16,538 -21,900 79.56%
Tax Rate - - - - - - - -
Total Cost 52,731 21,738 20,481 20,605 16,853 17,223 25,686 61.74%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -32,250.31 -12,393.10 -6,050.45 -13,367.32 -384.28 -2,414.31 -578.45 1370.20%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -1.12 -0.46 -0.43 -0.45 -0.34 -0.42 -0.55 60.86%
EPS Diluted -1.12 -0.46 -0.43 -0.45 -0.34 -0.42 -0.55 60.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.